Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze MREO stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate MREO investment potential.

What is MREO stock price today?

Get real-time MREO stock price, historical data, and price charts on Financhill. Track MREO performance with our advanced analysis tools.

Is MREO a good investment?

Evaluate MREO investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy MREO stock?

To buy MREO stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of MREO?

View detailed market capitalization data and company valuation metrics for MREO on our comprehensive analysis page.

What is the P/E ratio of MREO?

Use our fundamental analysis tools to view MREO P/E ratio and compare valuation metrics with industry peers.

What are MREO earnings?

View MREO earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Mereo BioPharma Group Plc 10K Form

Buy

MREO
Mereo BioPharma Group Plc

Last Price:

$2.29

Seasonality Move:

15.38%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MREO News And Ratings

See the #1 stock for the next 7 days that we like better than MREO

MREO Financial Statistics

Sales & Book Value

Annual Sales:	$0
Cash Flow:	$-7.3M
Price / Cash Flow:	0
Annual Sales:	$0.29
Price / Book:	7.85

Profitability

EPS (TTM):	-0.26360
Net Income (TTM):	$-41.7M
Gross Margin:	$-1.1M
Return on Equity:	-70.81%
Return on Assets:	-59.61%

Mereo BioPharma Group Plc Earnings Forecast

Key Mereo BioPharma Group Plc Financial Ratios

Per Share Earnings over the last 9 years have been positive in 5 years.

Mereo BioPharma Group Plc Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Biotechnology
Sector:	Health Care
Current Symbol:	MREO
CUSIP:	589492
Website:	mereobiopharma.com

Debt

Debt-to-Equity Ratio:	0.01
Current Ratio:	8.71
Quick Ratio:	8.09

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	0

MREO Technical Analysis vs Fundamental Analysis

Buy

Mereo BioPharma Group Plc (MREO) is a Buy

Is Mereo BioPharma Group Plc a Buy or a Sell?

Mereo BioPharma Group Plc stock is rated a Buy

The current Mereo BioPharma Group Plc [MREO] share price is $2.30. The Score for MREO is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.